All stories by Sushmi Dey
All life-saving drugs may come under price capRediff.com25 Oct 2014
NPPA suggests expanding the list of essential medicines whose prices are controlled
Ranbaxy staff get pay-cut shield in Sun buyoutRediff.com20 Oct 2014
Sun maintained it would retain the best of both organisations to build a global pharma company.
Ranbaxy's top executives in the US resignRediff.com14 Oct 2014
US country head, key departmental heads leave; more likely to follow.
Is India ready to fight Ebola? NO WAY!Rediff.com10 Oct 2014
No Ebola case detected in the country so far; experts say a robust preparedness plan to fight the virus missing.
Pharma firms to be hit as drug regulator caps pricesRediff.com19 Sep 2014
Currently, the govt directly caps prices of 348 formulations at the average price of all medicines in a particular segment with at least 1% market share
Gilead to allow 5 Indian firms to sell hepatitis generics in 90 countriesRediff.com15 Sep 2014
Among the companies likely to sign deals with Gilead are Cadila, Hetero, Strides Arcolab and Mylan, while Cipla is expected to earn active pharmaceutical ingredient rights.
Sun Pharma draws up plan to fix ailing RanbaxyRediff.com12 Sep 2014
It hopes to turn around Ranbaxy within four years of closing the deal by improving efficiency and resolving all regulatory issues
Drug price monitoring cells across states soonRediff.com8 Sep 2014
The idea is to keep a close watch on real-time price movements, the maximum retail price of medicines and their availability.
FDI policy for medical devices on the cardsRediff.com31 Aug 2014
Ministerial consultations on, with recognition of the potential, and the need to not classify it under the same rules as for pharmaceuticals.
Another big blow for RanbaxyRediff.com22 Aug 2014
Slapped with Rs 242-crore fine by US authorities for rule violations at Toansa unit, say sources; 2nd such hefty rap in the recent past from US regulators for bending rules.
US FDA India head quits; regulator goes for rejigRediff.com21 Jul 2014
Altaf Ahmed Lal, country head of the US Food and Drug Administration (US FDA) in India, has quit and so have a few other key officials at the American drug regulator's India office.
Sun, Ranbaxy hire Mckinsey for merger assistanceRediff.com18 Jul 2014
Sun-Ranbaxy are keen to complete the merger process.
Drug makers seek out-of-court settlement in clinical trial casesRediff.com10 Jun 2014
In a letter to health minister Harsh Vardhan, the Indian Pharmaceutical Alliance, an industry body representing leading pharma companies, including Sun Pharma, Lupin, Dr Reddy's Labs, Cadila Health and Glenmark, stressed the need for an out-of-court settlement with health activists fighting for the rights of clinical trial participants.
Drug makers told to give pricing details in 10 daysRediff.com6 Jun 2014
The Drug (Prices Control) Order implemented in May last year brought into its purview 652 packs of 348 formulations.
Now, buy medicines and stents on EMIRediff.com5 Jun 2014
The company did not respond to specific queries on the project's expansion.
Indian drug cos to benefit as US expedites generic clearancesRediff.com12 May 2014
Even smaller companies like Torrent Pharma and Alembic file five to 10 ANDAs every year.
Novartis-Glaxo deal signals pharma firms don't have it easyRediff.com24 Apr 2014
Experts say despite it being a global deal, the transaction will have to undergo CCI scrutiny because of the scale of operations.
Novartis-GSK-Eli Lilly deal may affect Indian marketRediff.com23 Apr 2014
On Tuesday, Novartis agreed to buy GSK's oncology products business for $14.5 billion, while selling its vaccines business, excluding flu, to GSK for $7.1 billion.
ICAI to ban three auditors in Satyam caseRediff.com23 Apr 2014
ICAI has also imposed a fine of Rs 5 lakh on each of the three accused in Satyam case.
Ranbaxy buy in line with Sun's strategyRediff.com17 Apr 2014
The company buys distressed assets across the globe and turns them around to not only add to its books but also its product pipeline and regions.